Cystic fibrosis: Therapeutic strategies are multiplying;Mucoviscidose: Les strategies therapeutiques se multiplient

Archives de Pediatrie

Volumn 5, Issue 11, 1998, Pages 1246-1252

  Clement, A ^a   Tamalet, A ^a   Fauroux, B ^a   Tournier, G ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Child; Cystic fibrosis; Gene therapy

Indexed keywords

AMILORIDE; NONSTEROID ANTIINFLAMMATORY AGENT; TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR PROTEIN, HUMAN;

CLINICAL FEATURE; CLONING VECTOR; CYSTIC FIBROSIS; ENZYME RECONSTITUTION; GENE THERAPY; HUMAN; PATHOPHYSIOLOGY; REVIEW; CHILD; GENETICS; MOLECULAR CLONING; MULTIMODALITY CANCER THERAPY; PROGNOSIS;

CHILD; CLONING, MOLECULAR; COMBINED MODALITY THERAPY; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENE THERAPY; HUMANS; PROGNOSIS;

EID: 0031741662     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0929-693x(98)81244-x     Document Type: Review

References (53)

1. F Collins Cystic Fibrosis: molecular biology and therapeutic implications Science 256 1992 774 779
2. M Welsh B Ramsey Research on cystic fibrosis Am J Respir Critic Care Med 157 1998 S148 S154
3. P Davis M Drumm M Konstan State of the art: cystic fibrosis Am J Respir Crit Care Med 154 1996 1229 1256
4. C Fuller D Benos CFTR Am J Physiol 263 1992 C267 C286
5. J Riordan The cystic fibrosis transmembrane conductance regualtor Annu Rev Physiol 55 1993 609 630
6. J Richman-Eisenstat Cytokine soup: making sense of inflammation in cystic fibrosis Pediatr Pulmonol 21 1996 3 5
7. M Konstan K Milliard T Norvell M Berger Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation Am J Respir Crit Care Med 150 1994 448 554
8. B Ramsey Management of pulmonary disease in patients with cystic fibrosis N Engl J Med 335 1996 179 188
9. S Delaney B Wainwright New pharmaceutical approaches to the treatment of cystic fibrosis Nature Med 2 1998 392 393
10. E Alton D Geddes Gene therapy for cystic fibrosis: a clinical perpective Gene Ther 2 1995 88 95
11. G Bellon L Caimard D Thouvenot V Jagneaux F Poitevin C Malcus Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial Hum Gene Therapy 8 1997 15 25
12. R Crystal N Mc Elvaney M Rosenfeld C Chu A Mastrangeli J Hay Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis Nature Genet 8 1994 42 51
13. R Korst N Mc Elvaney C Chu M Rosenfeld A Mastrangeli N Eissa Gene therapy for the respiratory manifestations of cystic fibrosis Am J Respir Crit Care Med 151 1995 575 587
14. J Zabner B Ramsey D Meeker M Aitken R Balfour R Gibson Repeat administration of an adenovirus encoding CFTR to the nasal epithelium of patients with CF J Clin Invest 97 1996 1504 1511
15. P Middleton E Alton Gene therapy for cystic fibrosis: which postman, which box? Thorax 53 1998 197 199
16. J Wilson Véhicules for gene therapy Nature 365 1995 691 692
17. W O'Neal A Beaudet Somatic gene therapy for cystic fibrosis Hum Mol Genet 3 1994 1497 1502
18. Cystic-Fibrosis-Conference-Nashville Pediatr Pulmonal Suppl 14 1997 1 352
19. N Caplen E Alton P Middleton J Dorin B Stevenson X Gao Liposome-mediated CFTR gene transfer for the nasal epithelium of patients with cystic fibrosis Nature Med 1 1995 6 13
20. A Mastrangeli C Danel M Rosenfeld L Stratford-Perricaudet M Perricaudet A Pavirani Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfert J Cin Invest 91 1993 225 234
21. S Clark R Kamen The human colony-stimulating factors Science 230 1987 1229 1232
22. J Nemunaitis Biological activities of hematopoietic growth factors that lead to future clinical applications Cancer Invest 12 1994 516 521
23. D Bedwell A Kaenjak D Benos Z Bebok J Bubien J Hong Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line Nature Med 3 1997 1280 1284
24. M Howard R Frizzell D Bedwell Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations Nature Med 2 1996 467 469
25. K Mc Caughan C Brown M Dalphin M Berry W Tate Translatic-nal termination efficiency in mammals is influenced by the base following the stop codon Proc Natl Acad Sci USA 92 1995 5431 5435
26. S Sato C Ward M Krause J Wine R Kopito Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation J Biol Chem 271 1996 635 638
27. S Cheng S Fang J Zabner J Marshall S Piraino S Schiavi Functional activation of the cystic fibrosis trafficking mutant Delta F 508-CFTR by overexpression Am J Physiol 268 1995 L615 L624
28. G Denning M Anderson J Amara J Marshall A Smith M Welsh Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive Nature 358 1992 761 764
29. G Lukacs X Chang C Bear N Kartner A Mohamed J Riordan The delta F 508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane J Biol Chem 268 1993 21592 21598
30. J Marshall S Fang L Ostedgaard C O’Riordan D Ferrara J Amara Stoichiometry of recombinant cystic fibrosis transmembrane conductance regulator in epithelial cells and its functional reconstitution into cells in vitro J Biol Chem 269 1994 2987 2995
31. T Kelley K Thomas L Milgram M Drumm In vivo activation of the cystic fibrosis transmembrane conductance regulator mutant delta F 508 in murine nasal epithelium Proc Natl Acad Sci USA 94 1997 2604 2608
32. B Cohen G Lee K Jacobson Y Kim Z Huang E Sorscher 8-cyclopentyl-1,3-dipropylxanthine and other xanthines differentially bind to the wild type and delta F 508 first nucleotide binding fold (NBF-1) domains of the cystic fibrosis transmembrane conductance regulator Biochemistry 36 1997 6455 6461
33. W Reenstra K Yurko-Mauro A Dam S Raman S Shorten CFTR chloride channel activation by genistein. The role of serine/threonine protein phosphatases Am J Physiol 271 1996 C650 C657
34. I Yang T Cheng F Wang E Price T Hwang Modulation of CFTR chloride channels by calyculin A and genistein Am J Physiol 272 1997 C142 C155
35. I Bowler B Kelman D Worthington J Littlewood A Waston S Conway Nebulized amiloride in respiratory exacerbations of cystic fibrosis: a randomised controlled trial Arch Dis Child 73 1995 427 430
36. A Graham A Hasani E Alton G Martin C Marriott M Hodson No added benefit from nebulized amiloride in patients with cystic fibrosis Eur Respir J 6 1993 1243 1248
37. M Knowles N Church W Waltner J Yankaskas P Gilligan M King A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis N Engl J Med 322 1990 1189 1194
38. K Olivier W Bennett K Hohneker K Zeman L Edwards R Boucher Acute safety and effects on mucociliary clearance of aerosolized uridine 5′-triphosphate ± amiloride in normal human adults Am J Respir Crit Care Med 154 1996 217 223
39. M Robinson J Regnis D Bailey M King G Bautovich P Bye Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis Am J Respir Crit Care Med 153 1996 1503 1509
40. A Visca E Bignamini Concentration of inhaled amiloride in cystic fibrosis Lancet 347 1996 1126
41. U Blank W Clauss W Weber Effects of benzamil in human cystic fibrosis airway epithelium Cell Physiol Biochem 5 1995 385 390
42. L Clarke R Boucher Chloride secretory response to extracellular ATP in normal and cystic fibrosis nasal epithelia Am J Physiol 263 1992 C348 C356
43. J Lallemand V Stoven J Annereau J Boucher S Blanquet J Barthe Induction by antitumoral drugs of proteins that functionally complement CFTR: a novel therapy for cystic fibrosis? Lancet 350 1997 711 712
44. T Khan J Wagener W Bost J Martinez F Accurso D Riches Early pulmonary inflammation in infants with cystic fibrosis Am J Respir Crit Care Med 151 1995 1075 1082
45. M Konstan P Byard C Hoppel P Davis Effect of high-dose ibuprofen in patients with cystic fibrosis N Engl J Med 332 1995 848 854
46. I Balfour-Lynn N Klein R Dinwiddie Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis Arch Dis Child 77 1997 124 130
47. H Eigen B Rosenstein S Fitz Simmons D Shidlow A multi center study of alternate day prednisone therapy in patients with cystic fibrosis J Pediatr 126 1995 515 523
48. W Nikolaizik M Schöni Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis J Pediatr 128 1996 271 274
49. P Birrer N Mc Elvaney A Rüdeberg C Wirz-Sommer S Liechti-Gallati R Kraemer Protease-antiprotease imbalance in the lungs of children with cystic fibrosis Am J Respir Crit Care Med 150 1994 207 213
50. N Mc Elvaney R Hubbard P Birrer M Chernick D Caplan M Frank Aerosol alpha-1-antitrypsin treatment for cystic fibrosis Lancet 337 1991 392 394
51. C Calleja J Pascussi J Mani P Maurel M Vilarem The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor Nature Med 4 1998 92 96
52. J Blanchard The ying and yang of rifampicin Nature Med 4 1998 14 15
53. J Smith S Travis E Greenberg M Welsh Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid Cell 85 1996 1 2